ⓘ Circumcision and HIV. Male circumcision reduces the risk of HIV transmission from women to men. In 2011, the World Health Organization and the Joint United Nati ..


ⓘ Circumcision and HIV

Male circumcision reduces the risk of HIV transmission from women to men. In 2011, the World Health Organization and the Joint United Nations Programme on HIV/AIDS stated that male circumcision is an efficacious intervention for HIV prevention if carried out by medical professionals under safe conditions. The United States Centers for Disease Control and Prevention states that circumcision reduces the risk that a man will acquire HIV and other sexually transmitted infections from an infected female partner.

A 2019 meta-analysis of men who have sex with men MSM found circumcision was associated with a 23% reduction in the odds of HIV infection. This was 42% in low and middle income countries. The CDC previously stated "There are as yet no convincing data to help determine whether male circumcision will have any effect on HIV risk for men who engage in anal sex with either a female or male partner, as either the insertive or receptive partner."


1. Recommendations

In 2007, the WHO reviewed the totality of evidence concerning male circumcision and HIV, and issued the following joint recommendations with UNAIDS.

  • Promoting male circumcision should be recognized as an additional, important strategy for the prevention of heterosexually acquired HIV infection in men.
  • Male circumcision should now be recognized as an efficacious intervention for HIV prevention.

Kim Dickson, coordinator of the working group that authored the report, commented:

  • Protection is incomplete. Men must continue to use condoms and limit the number of sexual partners.
  • Newly circumcised men should abstain from sex for at least six weeks.
  • The procedure must be done by a trained health care professional.
  • Male circumcision "would have greatest impact" in countries where the HIV infection rate among heterosexual males is greater than 15 percent and fewer than 20 percent of males are circumcised.

The World Health Organization WHO said: "Although these results demonstrate that male circumcision reduces the risk of men becoming infected with HIV, the UN agencies emphasize that it does not provide complete protection against HIV infection. Circumcised men can still become infected with the virus and, if HIV-positive, can infect their sexual partners. Male circumcision should never replace other known effective prevention methods and should always be considered as part of a comprehensive prevention package, which includes correct and consistent use of male or female condoms, reduction in the number of sexual partners, delaying the onset of sexual relations, and HIV testing and counselling."


1.1. Recommendations Men who have sex with men

A 2008 meta-analysis of gay and bisexual men 52% circumcised found that the rate of HIV infection was not lower among men who were circumcised. For men who engaged primarily in insertive anal sex, no effect was observed. Observational studies included in the meta-analysis that were conducted prior to the introduction of highly active antiretroviral therapy in 1996 demonstrated a protective effect for circumcised MSM against HIV infection.

A 2017 and 2011 review found some evidence that circumcision was protective in MSM.


1.2. Recommendations Programs

In 2011, UNAIDS prioritized 14 high HIV prevalence countries in eastern and southern Africa, with a goal of circumcising 80% of men 20.8 million by the end of 2016. In parallel, WHO developed a Framework for evaluating new, simpler circumcision techniques, which gave impetus to the development of two new devices Prepex and Shang Ring that are currently being scaled-up in the 14 high HIV prevalence countries. Overall, 14.5 million males were circumcised as of the end of 2016. UNAIDS Fast-Track Plan for ending the AIDS Epidemic by 2030 calls for an additional 25 million circumcisions in these high-priority countries by 2020, which will require to 5 million procedures per year, nearly double the current rate. To reach this goal, UNAIDS is counting on advances in circumcision techniques.

Newly circumcised men must refrain from sexual activity until the wounds are fully healed. Some circumcised men might have a false sense of security that could lead to increased risky sexual behavior.


2. Mechanism of action

Experimental evidence supports the theory that Langerhans cells part of the human immune system in foreskin may be a source of entry for the HIV virus. Excising the foreskin removes a main entry point for the HIV virus.


3.1. History Hypotheses and epidemiologic studies

Valiere Alcena, in a 1986 letter to the New York State Journal of Medicine, noted that low rates of circumcision in parts of Africa had been linked to the high rate of HIV infection. Aaron J. Fink several months later also proposed that circumcision could have a preventive role when the New England Journal of Medicine published his letter, "A possible explanation for heterosexual male infection with AIDS," in October, 1986. Alcena later said that Fink had expropriated his ideas.

By 2000, over 40 epidemiological studies had been conducted to investigate the relationship between circumcision and HIV infection. A meta-analysis conducted by researchers at the London School of Hygiene & Tropical Medicine examined 27 studies of circumcision and HIV in sub-Saharan Africa and concluded that these showed circumcision to be "associated with a significantly reduced risk of HIV infection" that could form part of a useful public health strategy.

A 2005 review of 37 observational studies expressed reservations about the conclusion because of possible confounding factors, since they were all observational and not experimental studies. The authors stated that three randomized controlled trials then underway in Africa would provide "essential evidence" about the effects of circumcision on preventing HIV.


3.2. History Randomized controlled trials in Africa

Three randomized controlled trials took place in South Africa, Kenya and Uganda. Southern and eastern Africa has the highest rate of adult HIV infection in the world.

The first trial to publish, in 2005, was that from South Africa, named ANRS-1265 or the "Orange Farm trial". After 18 months, there were 20 HIV infections incidence rate = 0.85 per 100 person-years in the intervention group and 49 2.1 per 100 person-years in the control group, a finding which led to suspension of the trial on ethical grounds. The other two African trials were also halted on ethical grounds, again because those in the circumcised group had a lower rate of new HIV infections than the control group.

The Orange Farm trial report concluded that circumcision offered protection against HIV infection "equivalent to what a vaccine of high efficacy would have achieved".

A 2009 systematic review from the Cochrane Collaboration included these 3 randomized controlled trials. It provided strong evidence that medical male circumcision reduces the acquisition of HIV by heterosexual men by about 60%, while adverse events are rare, and recommended inclusion of male circumcision into current HIV prevention guidelines. Sites for these studies were chosen specifically because of the high rates of HIVin those geographic areas.


4. Society and culture

The prevalence of circumcision varies across Africa. Studies were conducted to assess the acceptability of promoting circumcision; in 2007, country consultations and planning to scale up male circumcision programmes took place in Botswana, Kenya, Lesotho, Malawi, Mozambique, Namibia, Rwanda, South Africa, Swaziland, Uganda, Tanzania, Zambia and Zimbabwe.

The UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Male Circumcision for HIV Prevention found "large benefits" of circumcision in settings with high HIV prevalence and low circumcision prevalence. The Group estimated "one HIV infection being averted for every five to 15 male circumcisions performed, and costs to avert one HIV infection ranging from US$150 to US$900 using a 10-y time horizon". The World Health Organisation states that circumcision is "highly cost-effective" in comparison to other HIV interventions when data from the South African trial are used, but less cost-effective when data from the Ugandan trial are used.

  • affected by endemic HIV AIDS to promote circumcision as an additional method of controlling the spread of HIV In 2007 the WHO and the Joint United Nations
  • Male circumcision is the surgical removal of the foreskin prepuce from the human penis. The ethics of non - therapeutic circumcision being imposed on
  • The prevalence of circumcision is the percentage of males in a given population who have been circumcised. The rates vary widely by country, from virtually
  • circumcision has often been, and remains, the subject of controversy on a number of grounds - religious, ethical, sexual, and medical. In Classical and
  • prophylaxis Postexposure prophylaxis Voluntary Male Circumcision see also Circumcision and HIV Microbicides for sexually transmitted diseases Low dead
  • The distribution of circumcision and initiation rites throughout Africa, and the frequent resemblance between details of ceremonial procedure in areas
  • Circumcision surgical procedure in males involves either a conventional cut and stitch surgical procedure or use of a circumcision instrument or device
  • banning circumcision some dating back to ancient times, have been enacted in many countries and communities. In modern states, circumcision is generally
  • surrounding HIV and in turn have led to an increase in risky behaviour. Although prevention interventions, like safe male circumcision have been shown
  • Religious circumcision generally occurs shortly after birth, during childhood or around puberty as part of a rite of passage. Circumcision is most prevalent
  • showed that circumcision significantly reduced the risk of HIV infection. He subsequently helped design Kenya s circumcision program as an HIV AIDS prevention